Transchem Peer Comparison

NSE: TRANSCHEM | BSE: 500422

₹414.60

₹0.15 (0.04%)

As on 16-Oct-2026IST

Market cap

₹507 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

75.5

P/B Ratio

5.8

Div. Yield

0 %

Edit

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Market cap (₹ Cr)	507	31,674	26,307	26,224	25,017
Revenue (₹ Cr)	--	3,564	9,205	1,462	1,936
Net Profit (₹ Cr)	6.72	414.00	-371.81	387.35	288.22
Net Margin (%)	52.78	11.23	-3.93	26.01	14.79
RoE (%)	8.17	8.38	-3.85	25.18	29.77
Price to Earnings	75.47	77.44	--	67.90	86.80
Price-To-Book	5.83	6.29	3.29	15.20	18.64

Income Statement (₹ Cr)

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Operating Revenue	0.00	3,564.00	9,205.28	1,461.80	1,935.80
Total Income	12.74	3,686.00	9,449.59	1,489.25	1,948.58
Total Expenditure	4.06	2,792.00	8,195.15	919.25	1,485.56
EBITDA	-4.06	772.00	1,010.13	542.56	450.24
Depreciation	0.06	226.00	857.51	37.68	50.83
EBIT	-4.12	546.00	152.62	504.88	399.41
Interest	0.01	217.00	342.73	3.77	40.84
Other Income	12.74	122.00	244.31	27.45	12.78
Exceptional Items	0.00	12.00	-216.88	0.00	0.00
Profit before Tax	8.61	463.00	-162.68	528.56	371.35
Provision for Tax	1.89	49.00	209.13	141.21	83.14
Profit after Tax	6.72	414.00	-371.81	387.35	288.22

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Shareholder's Funds	83.58	4,940.00	8,162.62	1,653.56	1,288.82
Minority Interest	0.00	-5.00	0.00	-1.13	0.00
Non-Current Liabilities	0.16	1,712.00	5,044.14	42.40	202.03
Current Liabilities	4.00	1,622.00	4,758.28	230.82	835.87
Total Liabilities	87.73	8,578.00	17,723.32	1,983.96	2,326.71

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Non-Current Assets	2.20	5,343.00	10,211.52	1,026.85	519.60
Current Assets	85.48	2,606.00	7,191.66	881.27	1,681.81
Total Assets	87.73	8,578.00	17,723.32	1,983.96	2,326.71
Total Debt*	0.00	2,125.00	5,495.48	26.49	259.37
Net Current Assets	81.49	984.00	2,433.38	650.46	845.94
Contingent Liabilities	--	768.26	95.72	17.25	19.09

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Cash From Operating Activities	-1.57	390.00	1,652.60	292.17	205.05
Cash Flow from Investing Activities	1.65	-241.00	-826.03	-265.94	-409.72
Cash from Financing Activities	--	-54.00	-38.98	4.10	283.07
Net Cash Inflow / Outflow	0.09	95.00	787.59	30.33	78.39

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
ROCE (%)	6.89	6.79	1.24	32.42	29.22
ROE (%)	8.17	8.38	-3.85	25.18	29.77
ROA (%)	8.03	4.94	-2.21	21.93	24.77
EBIT Margin (%)	--	15.32	1.66	34.54	20.63
Net Margin (%)	52.78	11.23	-3.93	26.01	14.79
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Revenue Growth (%)	-100.00	18.37	0.78	40.90	46.65
EBIT Growth (%)	-178.26	252.26	-70.53	124.50	62.13
Net Profit Growth (%)	47.55	377.85	-1,383.43	104.15	89.49
EPS Growth (%)	47.55	1,001.33	-484.84	42.32	78.60
Book Value Growth (%)	5.37	13.47	0.33	26.03	144.31

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Price / Earnings	75.47	79.49	-84.07	67.90	85.46
Price / Book Value	5.83	6.29	3.29	15.20	18.64
Dividend Yield (%)	0.00	0.00	0.00	0.08	0.10
EV/EBITDA	-114.54	42.92	30.14	47.97	55.37
Market Cap (₹ Cr)	--	19,071.62	18,108.89	20,944.75	12,753.19

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Debt to Equity	0.00	0.31	0.53	0.02	0.11
Short term debt to equity ratio	--	0.09	0.09	0.02	0.05
Current Ratio	21.39	1.61	1.51	3.82	2.01
Quick Ratio	21.39	1.06	0.87	2.82	1.14
Interest Coverage	1,077.25	3.13	0.53	141.16	10.09

	Transchem	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Debtors to sales (%)	--	16.50	23.44	24.80	26.28
Asset Turnover	0.00	0.43	0.55	0.83	1.66
Receivable days	--	58.75	78.20	88.98	40.13
Inventory Days	--	75.82	93.30	56.04	60.29
Payable days	--	186.21	226.14	99.95	232.47
Cash Conversion Cycle	--	-51.64	-54.64	45.07	-132.04

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.